Citation: Mg. Kelly et al., Comparing flow cytometry of sputum, bronchoalveolar lavage, and peripheralblood cells in healthy individuals, CLIN IMMUNO, 99(1), 2001, pp. 100-100
Authors:
Moore, JE
Coenye, T
Vandamme, P
Elborn, JS
Citation: Je. Moore et al., First report of Pandoraea norimbergensis isolated from food - potential clinical significance, FOOD MICROB, 18(1), 2001, pp. 113-114
Authors:
Moore, JE
McIlhatton, B
Shaw, A
Murphy, PG
Elborn, JS
Citation: Je. Moore et al., Occurrence of Burkholderia cepacia in foods and waters: Clinical implications for patients with cystic fibrosis, J FOOD PROT, 64(7), 2001, pp. 1076-1078
Authors:
Moore, JE
Crowe, M
Shaw, A
McCaughan, J
Redmond, AOB
Elborn, JS
Citation: Je. Moore et al., Antibiotic resistance in Burkholderia cepacia at two regional cystic fibrosis centres in Northern Ireland: is there a need for synergy testing?, J ANTIMICRO, 48(2), 2001, pp. 319-321
Authors:
Moore, JE
Shaw, AB
Stanley, T
Crowe, MJ
Elborn, JS
Citation: Je. Moore et al., Long-term preservation of strains of Burkholderia cepacia, Pseudomonas spp. and Stenotrophomonas maltophilia isolated from patients with cystic fibrosis, LETT APPL M, 33(1), 2001, pp. 82-83
Authors:
Moore, JE
Millar, BC
Jiru, X
McCappin, J
Crowe, M
Elborn, JS
Citation: Je. Moore et al., Rapid characterization of the genomovars of the Burkholderio cepacia complex by PCR-single-stranded conformational polymorphism (PCR-SSCP) analysis, J HOSP INF, 48(2), 2001, pp. 129-134
Authors:
McDowell, A
Mahenthiralingam, E
Moore, JE
Dunbar, KEA
Webb, AK
Dodd, ME
Martin, SL
Millar, BC
Scott, CJ
Crowe, M
Elborn, JS
Citation: A. Mcdowell et al., PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients, J CLIN MICR, 39(12), 2001, pp. 4247-4255
Authors:
Wright, RM
Moore, JE
Shaw, A
Dunbar, K
Dodd, M
Webb, K
Redmond, AOB
Crowe, M
Murphy, PG
Peacock, S
Elborn, JS
Citation: Rm. Wright et al., Improved cultural detection of Burkholderia cepacia from sputum in patients with cystic fibrosis, J CLIN PATH, 54(10), 2001, pp. 803-805
Authors:
McCloskey, M
McCaughan, J
Redmond, AOB
Elborn, JS
Citation: M. Mccloskey et al., Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis, IRISH J MED, 170(1), 2001, pp. 28-31
Authors:
Hendry, J
Nixon, L
Dodd, M
Elborn, JS
Govan, J
Shale, DJ
Webb, AK
Citation: J. Hendry et al., Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia, PEDIAT PULM, 29(1), 2000, pp. 8-10
Authors:
Hendry, J
Butler, S
Elborn, JS
Govan, JRW
Nelson, J
Shale, DJ
Webb, AK
Citation: J. Hendry et al., Antibody response to Burkholderia cepacia in patients with cystic fibrosiscolonized with Burkholderia cepacia and Pseudomonas aeruginosa, J INFECTION, 40(2), 2000, pp. 164-170
Authors:
Elborn, JS
Prescott, RJ
Stack, BHR
Goodchild, MC
Bates, J
Pantin, C
Ali, N
Shale, DJ
Crane, M
Citation: Js. Elborn et al., Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs, THORAX, 55(5), 2000, pp. 355-358
Authors:
Bell, SC
Bowerman, AM
Nixon, LE
Macdonald, IA
Elborn, JS
Shale, DJ
Citation: Sc. Bell et al., Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis, EUR J CL IN, 30(6), 2000, pp. 553-559
Authors:
Hendry, J
Elborn, JS
Nixon, L
Shale, DJ
Webb, AK
Citation: J. Hendry et al., Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa, EUR RESP J, 14(2), 1999, pp. 435-438
Authors:
Bell, SC
Elborn, JS
Nixon, LE
Macdonald, IA
Shale, DJ
Citation: Sc. Bell et al., Repeatability and methodology of resting energy expenditure in patients with cystic fibrosis, RESP PHYSL, 115(3), 1999, pp. 301-307
Authors:
Bradley, JM
Wallace, ES
Elborn, JS
Howard, JL
McCoy, MP
Citation: Jm. Bradley et al., An audit of the effect of intravenous antibiotic treatment on spirometric measures of pulmonary function in cystic fibrosis, IRISH J MED, 168(1), 1999, pp. 25-28